[ET Net News Agency, 7 November 2024] Daiwa lowered the target price for Tigermed
(03347) to HKD40 from HKD49 and downgraded the rating to "hold" from "outperform".
The research house said the growth visibility was dragged by weak domestic demands in
clinical studies. (rc)